|
Volumn 393, Issue 1-2, 2010, Pages 55-60
|
Rapidfilm®: An innovative pharmaceutical form designed to improve patient compliance
|
Author keywords
Bioequivalence; Delivery system; Ondansetron; Orally disintegrating tablet (ODT); Orodispersible film; Orodispersible tablet
|
Indexed keywords
ONDANSETRON;
ANTIEMETIC AGENT;
DRUG CARRIER;
SEROTONIN ANTAGONIST;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
BLURRED VISION;
CLINICAL TRIAL;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISPERSIBLE TABLET;
DIZZINESS;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG DOSAGE FORM;
DRUG DOSAGE FORM COMPARISON;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG INDUCED HEADACHE;
DRUG TOLERABILITY;
FEMALE;
HEMATOCHEZIA;
HERPETIC STOMATITIS;
HUMAN;
HUMAN EXPERIMENT;
MALE;
MAXIMUM PLASMA CONCENTRATION;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
TIME TO MAXIMUM PLASMA CONCENTRATION;
VOLUNTEER;
ANALYSIS OF VARIANCE;
BLOOD;
CHEMISTRY;
COMPARATIVE STUDY;
DRUG FORMULATION;
LIQUID CHROMATOGRAPHY;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
PHARMACOKINETICS;
TANDEM MASS SPECTROMETRY;
ADMINISTRATION, ORAL;
ADULT;
ANALYSIS OF VARIANCE;
ANTIEMETICS;
CHEMISTRY, PHARMACEUTICAL;
CHROMATOGRAPHY, LIQUID;
CROSS-OVER STUDIES;
DOSAGE FORMS;
DRUG CARRIERS;
DRUG COMPOUNDING;
FEMALE;
HUMANS;
MALE;
ONDANSETRON;
PATIENT COMPLIANCE;
SEROTONIN ANTAGONISTS;
TANDEM MASS SPECTROMETRY;
THERAPEUTIC EQUIVALENCY;
|
EID: 77953359181
PISSN: 03785173
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijpharm.2010.03.055 Document Type: Article |
Times cited : (31)
|
References (7)
|